Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy

被引：40

作者：

Menzer, Christian ^{[1
,2
]}

Beedgen, Bernd ^{[3
]}

Rom, Joachim ^{[4
]}

Duffert, Christin M. ^{[5
]}

Volckmar, Anna-Lena ^{[6
]}

Sedlaczek, Oliver ^{[7
,8
]}

Richtig, Erika ^{[9
]}

Enk, Alexander ^{[10
]}

Jaeger, Dirk ^{[11
,12
,13
]}

Hassel, Jessica C. ^{[1
]}

机构：

[1] Heidelberg Univ, Sect DermatoOncol, Dept Dermatol, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[2] Mem Sloan Kettering Canc Ctr, Dermatol Serv, 1275 York Ave, New York, NY 10021 USA

[3] Heidelberg Univ, Div Neonatol, Dept Pediat, Sch Med, Neuenheimer Feld 430, D-69120 Heidelberg, Germany

[4] Univ Hosp, Dept Obstet & Gynecol, Heidelberg, Germany

[5] Heidelberg Univ, Dept Pediat, Heidelberg, Germany

[6] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany

[7] Univ Hosp Heidelberg, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[8] Univ Hosp Heidelberg, Dept Diagnost Radiol, German Canc Res Ctr DKFZ, Heidelberg, Germany

[9] Med Univ Graz, Dept Dermatol, Graz, Austria

[10] Heidelberg Univ, Dept Dermatol, Heidelberg, Germany

[11] Univ Hosp Heidelberg, Natl Ctr Tumor Dis NCT, Dept Med Oncol & Internal Med 6, Heidelberg, Germany

[12] German Canc Consortium DKTK, Heidelberg, Germany

[13] German Canc Res Ctr, Appl Tumor Immun, Heidelberg, Germany

来源：

EUROPEAN JOURNAL OF CANCER | 2018年 / 104卷

关键词：

MALIGNANT-MELANOMA; ANTIBODIES; BLOCKADE;

D O I：

10.1016/j.ejca.2018.09.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：239 / 242

页数：4

共 12 条

[1] Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infant [J].

Alexander, A ;

Samlowski, WE ;

Grossman, D ;

Bruggers, CS ;

Harris, RM ;

Zone, JJ ;

Noyes, RD ;

Bowen, GM ;

Leachman, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) :2179-2186

[2] Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis [J].

Bertrand, Anne ;

Kostine, Marie ;

Barnetche, Thomas ;

Truchetet, Marie-Elise ;

Schaeverbeke, Thierry .

BMC MEDICINE, 2015, 13

[3] Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets [J].

Bugelski, Peter J. ;

Martin, Pauline L. .

BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (03) :823-846

[4] Hormones, nevi, and melanoma: An approach to the patient [J].

Driscoll, Marcia S. ;

Grant-Kels, Jane M. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) :919-931

[5] New systemic agents in dermatology with respect to fertility, pregnancy, and lactation [J].

Grunewald, Sonja ;

Jank, Alexander .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (04) :277-292

[6] Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions [J].

Hassel, Jessica C. ;

Heinzerling, Lucie ;

Aberle, Jens ;

Baehr, Oliver ;

Eigentler, Thomas K. ;

Grimm, Marc-Oliver ;

Gruenwald, Victor ;

Leipe, Jan ;

Reinmuth, Niels ;

Tietze, Julia K. ;

Trojan, Joerg ;

Zimmer, Lisa ;

Gutzmer, Ralf .

CANCER TREATMENT REVIEWS, 2017, 57 :36-49

[7]

Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1

[8] Applicability of reference values for the determination of serum S100 protein as a marker of malignant melanoma in children [J].

Hunzelmann, N ;

Kurschat, P ;

Hani, N ;

Jarisch, A ;

Mauch, C .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (03) :536-537

[9] Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy [J].

Maleka, Aglaia ;

Enblad, Gunilla ;

Sjors, Gunnar ;

Lindqvist, Anna ;

Ullenhag, Gustav J. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) :E192-E193

[10]

Mehta Andrew, 2018, J Glob Oncol, V4, P1, DOI 10.1200/JGO.17.00019

← 1 2 →